You have accessed back-upped version of our site. Please reffer to new home page for a more up-to-date information.

Virtual screening services

Quantum is a leading company providing drug screening services in-silico and, thus, delivering to it clients strong inhibitors against variety of target-proteins

We apply our proprietary developed computational technology QUANTUM, which shows outstanding accuracy in forecasting binding affinities. The hit rate of the QUANTUM performance is about 50%, it means that a half of found in silico strong inhibitors would be confirmed in in-vitro testing!!!

Click here to download a brochure about QUANTUM hit Identification technology.

PDB ID: 2BQI
Title: CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
	Functional Class: Hydrolase Primary citation: Takano, K.,Yamagata, Y.,Yutani, K. A general rule for the relationship between hydrophobic effect and conformational stability of a protein: stability and structure of a series of hydrophobic mutants of human lysozyme. J.Mol.Biol. v280 pp.749-761, 1998

Abstract Title: A general rule for the relationship between hydrophobic effect and conformational stability of a protein: stability and structure of a series of hydrophobic mutants of human lysozyme.

Keywords: Proteins, Humans, Support, Research, (2bqi:_), 2bqi00, (homo, Molecular, Hydrolase, Orthogonal, Models, Lysozyme, Conformation, Bundle, Muramidase, D2bqi__, Sapiens), Alpha, C-type, Sapiens, Calorimetry, Mutagenesis, Lysozyme, Lysozyme-like, Beta, Non-u.s., Lysozyme, Mainly, Homo, Human, Protein, Crystallography, Gov't, (a+b), X-ray, Focused compound library, Targeted chemical collection, Pre-selected, Prescreened, Measurement, Estimation, Prediction, Hts, Uhts, High throughput screening, Ultra high-throughput screening, Development, Profiling, Hit, Lead, Hits, Leads, Drug candidate, Chemicals, Entity, Therapeutic agents, Small molecules, In vitro, Novel active compounds, Focused compound library, Targeted hit library, Entities collection, In-vitro, Vendors, Providers, Distributors, Cro, Medicinal chemists, Diverse range, Structurally diverse building blocks, Hit rich collection, Synthesized, Develop new focused arrays, Privileged scaffolds profile, Profiling, Pre-screened, Methods and principles in medicinal chemistry, Synthetic organic, Computational chemistry, Subset of, Broad variety of organic compounds, Diversity analysis, Synthetic tractability and drug like properties, Computer-aided, Optimization,